Filip de Vos

Assistant Professor - medical

Strategic program(s):

Biography

Education

1993 – 1996

1996 – 2000

2004

2010

Pre-MedicalSchool at Limburg UniversityCenter, Hasselt, Belgium

MedicalSchool at University of Antwerp, Antwerp, Belgium (MD)

PhD thesis: “Balance between desired and unwanted effects of chemotherapeutic and anti-angiogenic drugs” at department of Medical Oncology at the University of Groningen, The Netherlands

Degree: Medical Oncologist, University of Rotterdam, The Netherlands

Additional training

2013

2014

12th Masterclass in Clinical Oncology by the European School of

Oncology (ESO) and European Society of Medical Oncology

(ESMO)

Clinical Trial Statistics for Non-Statisticians by the European

Organization for Research and Treatment in Cancer (EORTC)

Basic Course Legislation and Organization for Clinical Researchers

(BROK)

Professional experience

2008 – 2010

2010 – 2011

2011 – present

Fellow, Dept of Medical Oncology, ErasmusMedical Center, Rotterdam, The Netherlands

Staff member, Dept of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Staff member, Dept of Medical Oncology, University of Utrecht, Utrecht, the Netherlands

Since start of PhD thesis extensive experience with clinical trials

Strategic program(s):

Contact

fvos@umcutrecht.nl

Pure profile

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

All publications

Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands Mark P van Opijnen, Marike L D Broekman, Edwin Cuppen, Hendrikus J Dubbink, Arja Ter Elst, Ronald van Eijk, Angelika Mühlebner, Casper Jansen, Robert van der Geize, Ernst-Jan M Speel, Patricia J T A Groenen, Filip Y F de Vos, Pieter Wesseling, Wendy W J de Leng, Sybren L N Maas
Journal of Neuro-Oncology, 2024, vol. 166, p.485-492

Focused Ultrasound-Enhanced Liquid Biopsy Akke Bakker, Anna E Ixkes, Hema Venugopal, Mario G Ries, Nathalie S M Lak, Filip Y F L de Vos, Dannis G van Vuurden, Tom J Snijders
Cancers, 2024, vol. 16, p.1-15

The role of molecular biomarkers in recurrent glioblastoma trials Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marjolein Geurts, Sybren L N Maas, Marike L D Broekman
Medical Oncology, 2024, vol. 41

Recurrent glioblastoma in national guidelines on the diagnosis and treatment of gliomas Mark P. van Opijnen, Rob J.A. Nabuurs, Filip Y.F. de Vos, Mohini T.R. Ramsoedh, Joost J.C. Verhoeff, Marjolein Geurts, Marike L.D. Broekman
Brain and Spine, 2024, vol. 4

The Differentiation between Progressive Disease and Treatment-Induced Effects with Perfusion-Weighted Arterial Spin-Labeling in High-Grade Gliomas Christina Maria Flies, Tom Jan Snijders, Beverly Iendra De Leeuw, Emiel Alexander van Maren, Bart Jean Pieter Kersten, Joost Jacobus Cornelis Verhoeff, Filip Yves Francine De Vos, Pierre Alain Robe, Jeroen Hendrikse, Jan Willem Dankbaar
AJNR. American journal of neuroradiology, 2024, vol. 45, p.920-926

Marizomib for patients with newly diagnosed glioblastoma Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih, Jean-Sébastien Frenel, Emilie Le Rhun, Juan Manuel Sepulveda, James Perry, G Laura Masucci, Pierre Freres, Hal Hirte, Clemens Seidel, Annemiek Walenkamp, Slavka Lukacova, Paul Meijnders, Andre Blais, Francois Ducray, Vincent Verschaeve, Garth Nicholas, Carmen Balana, Daniela A Bota, Matthias Preusser, Sarah Nuyens, Fréderic Dhermain, Martin van den Bent, Chris J O'Callaghan, Maureen Vanlancker, Warren Mason, Michael Weller,
Neuro-oncology, 2024, vol. 26, p.1670-1682

External positions

lid werkgroep Richtlijnen Palliatieve Zorg - coordinatie/organisatie richtlijnen rondom palliatieve zorg - NIV